Enhancement of dopamine mediated behaviour by the NMDA antagonists MK-801 and CPP: Similarities with repeated electroconvulsive shock

Psychopharmacology

Volumn 133, Issue 1, 1997, Pages 85-94

  Smith, S E ^a   Acton, L ^a   Sharp, T ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Behaviour; Dopamine agonist; Electroconvulsive shock (ECS); NMDA antagonist; Nucleus accumbens

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; APOMORPHINE; DIZOCILPINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; QUINPIROLE; SKF 1297; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CONVULSION; DOPAMINERGIC SYSTEM; DRUG EFFECT; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; DIZOCILPINE MALEATE; DOPAMINE AGONISTS; ELECTROSHOCK; EXCITATORY AMINO ACID ANTAGONISTS; INJECTIONS, INTRAVENTRICULAR; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0030773383     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050375     Document Type: Article

References (62)

1. Ainsworth K, Smith SE, Sharp T (1997) Chronic lamotrigine administration enhances the locomotor response to apomorphine in the rat. Pharmacologist 39:120
2. Albin RL, Makowiec RL, Hollingsworth ZR, Dure LS, Penney JB, Young AB (1992) Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience 46:35-48
3. Andersen K, Balldin J, Gottfries CG, Granerus AK, Modigh K, Svennerholm L, Wallin A (1987) A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with "on-off" phenomena. Acta Neurol Scand 76:191-199
4. 2 receptor sites in reserpine-treated but not in normal rats. Eur J Pharmacol 113:79-88
5. Barkai AI, Durkin M, Nelson HD (1990) Localised alterations of dopamine receptor binding in the rat brain by repeated electroconvulsive shock: an autoradiographic study. Brain Res 529:208-213
6. Carlsson M, Carlsson A (1989) Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice. J Neural Transm 77:65-71
7. 2 dopamine receptor classification and its functional implications. Synapse 1: 347-388
8. Cookson J, Kundu S, Anderson J, Calabrese JR, Bowden C, McElroy S, Stubbs D, Corn T, Ascher J (1996) Lamotrigine in treatment-refractory bipolar disorder. J Psychopharmacol 10 [suppl]:A39
9. Corbett D (1989) Possible abuse potential of the NMDA antagonist MK-801. Behav Brain Res 34:239-246
10. Dall'Olio R, Rimondini R, Gandolfi O (1995) The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function. Psychopharmacology 118:310-315
11. 2 mediated behaviors in intact rats. Psychopharmacology 123:187-190
12. 2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats. Brain Res 487:267-277
13. Green AR, Nutt DJ (1987) Psychopharmacology of repeated seizures: possible relevance to the mechanism of action of electroconvulsive therapy. In: Iversen LL, Iverssen SD, Snyder SH (eds) Handbook of psychopharmacology. Plenum Press, New York, pp 375-419
14. Green AR, Vincent N (1987) The effect of repeated electroconvulsive shock on GABA synthesis and release in regions of rat brain. Br J Pharmacol 92:19-24
15. Green AR, Bloomfield MR, Atterwill CK, Costain DW (1979) Electroconvulsive shock reduces the cataleptogenic effect of both haloperidol and arecoline in rats. Neuropharmacology 18:147-154
16. Heal DJ, Green AR (1978) Repeated electroconvulsive shock increases the behavioural responses of rats to injection of both dopamine and dibutyryl cyclic AMP into the nucleus accumbens. Neuropharmacology 23:1241-1251
17. Heninger GR, Charney DS (1987) Mechanism of action of antidepressant treatments: implications for the etiology and treatment of depressive disorders. In: Psychopharmacology: the third generation of progress. Raven Press, New York, pp 535-544
18. Jones DL, Mogenson GJ (1980) Nucleus accumbens to globus pallidus GABA projection subserving ambulatory activity. Am J Physiol 238:R65-R69
19. Kaddis FG, Wallace LJ, Uretsky NJ (1993) AMPA/kainate antagonists in the nucleus accumbens inhibit locomotor stimulatory response to cocaine and dopamine agonists. Pharmacol Biochem Behav 46:703-708
20. Leach MJ, Baxter MG, Critchley MA (1991) Neurochemical and behavioural aspects of lamotrigine. Epilepsia 32 [suppl 2]:S4-S8
21. Lehmann J, Schneider J, McPherson S, Murphy DE, Bernard P, Tsai C, Bennet DA, Pastor G, Stell DJ, Boehm C, Cheney DL, Liebman JM, Williams M, Wood PL (1987) CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo. J Pharmacol Exp Ther 240:737-746
22. Loscher W, Honack D, Fassbender CP (1991) Regional alterations in brain amino acids after administration of the N-methyl-D-aspartate receptor antagonists MK-801 and CGP 39551 in rats. Neurosci Lett 124:115-118
23. Loscher W, Annies R, Honack D (1993) Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats. Eur J Pharmacol 242:263-274
24. 2A receptors in rat brain. Br J Pharmacol 117:329P
25. Maj J, Rogoz Z, Skuza G (1992) The effects of combined treatment with MK-801 and antidepressant drugs in the forced swimming test in rats. Pol J Pharmacol Pharm 44:217-226
26. Meloni D, Gambrana C, De Montis MG, Dal Pra P, Taddei I, Tagliamonte A (1993) Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats. Pharmacol Biochem Behav 46:423-426
27. 1 dopamine receptor agonist SKF 38393 and its R- and S-enantiomers in the intact adult rat. Psychopharmacology 92:164-168
28. 2 receptor antagonists. Eur J Pharmacol 237:1-7
29. 2-mediated behaviour in the 6-hydroxydopamine model of turning: relationship with c-fos expression. J Pharmacol Exp Ther 260:402-408
30. Morelli M, Fenu S, Di Chiara G (1992b) Blockade of N-methyl-D-aspartate receptors potentiates dopaminergic responses in the 6-OHDA model of Parkinson: differential role of D-1 and D-2 receptors. Neurochem Int 20 [suppl.]:261S-264S
31. Nevins ME, Arnolde SM (1989) A comparison of the anticonvulsant effects of competitive and non-competitive antagonists of the N-methyl-D-aspartate. Brain Res 503:1-4
32. Nowak G, Trullas R, Layer RT, Skolnick P, Paul IA (1993) Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. J Pharmacol Exp Ther 265: 1380-1386
33. Ouagazzal A, Nieoullon A, Amalric M (1994) Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum. Eur J Pharmacol 251:229-236
34. Paul IA, Trullas R, Skolnick P, Nowak G (1992) Down-regulation of cortical β-adrenoceptors by chronic treatment with functional NMDA antagonists. Psychopharmacology 106:285-287
35. Paul IA, Layer RT, Skolnick P, Nowak G (1993) Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine. Eur J Pharmacol 247:305-311
36. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, New York
37. Pijnenburg AJJ, Van Rossum JM (1973) Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens. J Pharm Pharmacol 25:1003-1005
38. 2 receptors regulating rat locomotor activity. Psychopharmacology 99:558-562
39. Rao TS, Cler JA, Mick SJ, Emmett MR, Farah JM Jr, Contreras PC, Iyenger S, Wood PL (1991) Neurochemical interactions of competitive N- methyl-D-aspartate antagonists with dopaminergic neurotransmission and the cerebellar cyclic GMP system: functional evidence for a phasic glutamatergic control of the nigrostriatal dopaminergic pathway. J Neurochem 56:907-913
40. Sato K, Morimoto K, Hiramatsu M, Mori A, Otsuki S (1989) Effect of a noncompetitive antagonist (MK-801) of NMDA receptors on convulsions and brain amino acid level in E1 mice. Neurochem Res 14:741-744
41. 2 agonist-induced behavioural responses in rats. Psychopharmacology 100:110-114
42. 2-like dopamine receptors. Psychopharmacology 133:77-84
43. 2 receptor mRNA in the nucleus accumbens of the rat. Psychopharmacology 120: 333-340
44. 2 balance in the basal ganglia and its relevance to Parkinson's disease. Synapse 19: 264-293
45. 2 receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse. Eur J Pharmacol 250:239-246
46. 2 agonists in reserpine-treated mice. Psychopharmacology 114:469-476
47. 2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice. J Neural Transm 88:235-240
48. Svensson A, Carlsson ML, Carlsson A (1995) Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice. J Neural Transm 101: 127-148
49. 2 dopamine receptors in the nucleus accumbens. Neuropharmacology 30:259-266
50. Tallaksen-Greene SJ, Wiley RG, Albin RL (1992) Localisation of striatal excitatory amino acid binding site subtypes to striatonigral projection neurons. Brain Res 594:165-170
51. Totterdel S, Smith AD (1989) Convergence of hippocampal and dopaminergic input onto identified neurons in the nucleus accumbens of the rat. J Chem Neuroanat 2:285-298
52. Trullas R, Skolnick P (1990) Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 185:1-10
53. Verma A, Kulkarni SK (1992) Modulation of MK-801 response by dopaminergic agents in mice. Psychopharmacology 107: 431-436
54. Waldmeier PC, Baumann PA, Wicki P, Feldtrauer JJ, Stierlin C, Schmutz M (1995) Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology 45:1907-1913
55. 1 receptors. Brain Res 622:325-329
56. 2 interactions. In: Waddington J (ed) Dopamine receptor interactions. Academic Press, New York, pp 78-114
57. 2 dopamine receptors in the rat nucleus accumbens. J Neurosci 6:274-280
58. Wilkin JM (1993) Blockade of the locomotor stimulant effects of cocaine and methamphelamine by glutamate antagonists. Life Sci 53:406-410
59. Wong EHF, Kemp JA, Preisley T, Knight AR, Woodruff GN, Iversen LL (1986) The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci USA 83: 7104-7108
60. Woodruff GN, Foster AC, Gill R, Kemp JA, Wong EHF, Iversen LL (1987) The interaction between MK-801 and receptors for N-methyl-D-aspartate: functional consequences. Neuropharmacology 26:903-909
61. Worms P, Lloyd KG (1978) Influence of GABA-agonists and antagonists on neuroleptic-induced catalepsy in rats. Life Sci 23: 475-478
62. Yang CR, Mogenson GJ (1984) Electrophysiological responses of neurons in the nucleus accumbens to hippocampal stimulation and the attenuation of the excitatory responses by the mesolimbic dopamine system. Brain Res 324:69-84